Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Modern Healthcare Technology Holdings Limited (0919.HK)
Hong Kong, HK
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, Mainland China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care and anti-ageing, and referral services on plastic reconstruction; slimming services, including weight management programs; spa and massage services comprising resplendent bathroom furnishings and a hydrotherapeutic pool, as well as foot spa, and foot treatment and massage services; and haircare and removal, make-up, joint and intimate care, and body check and genetic test services. The company also sells skincare and wellness products under the be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Mu-lan Spa, Cellnoc, Veribel, Castille, Dr Plus, IconX, Eclat du teint, and Natural Care brand names. In addition, it provides sub-franchising services in relation to beautification and gymnastic services; beauty and wellness treatment training program; property holding services; food and beverage services; fund management services; advertising services; maid agency services; licensing services; and management services, as well as holds property leases. The company was formerly known as Modern Beauty Salon Holdings Limited and changed its name to Modern Healthcare Technology Holdings Limited. The company was incorporated in 2005 and is headquartered in Kowloon Bay, Hong Kong.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.26% | +1.03% | +12.64% | +7.69% | +30.67% | +30.67% | +13.95% | -34.67% | -65.00% | -78.46% | -89.35% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Personal Products & Services: +6.6%-0.3% Q3'25: +6.2% (vs Q3'23)
-
EPS growth Personal Products & Services: +19.6%+47.2% ★ Q3'25: +122.6% (vs Q3'23)
-
FCF margin FCF growth · Personal Products & Services: +11.7%+22.5% ★ Q3'25: +18.8% (vs Q3'23)
-
EBIT margin Personal Products & Services: +10.5%+0.3% Q3'25: +9.2% (vs Q3'23)
-
ROIC Personal Products & Services: +6.9%+6.2% Q3'25: -197.2% (vs Q3'23)
-
Share dilution Personal Products & Services: +0.0%+0.0% Q3'25: +0.0% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×0.89× ★ Q3'25: 0.56× (vs Q3'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
|---|---|
| Revenue |
586.53M
est: 587.00M (-0.1%)
|
| EBITDA |
151.40M
est: 139.30M (+8.7%)
|
| EBIT |
107.49M
est: 15.55M (+591.3%)
|
| Net Income |
44.03M
|
| SGA |
9.63M
est: 35.84M (-73.1%)
|
| EPS |
0.12
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A+ | 5/5 | 5/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-27 | A+ | 5/5 | 5/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-26 | A+ | 5/5 | 5/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-22 | A+ | 5/5 | 5/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-20 | A+ | 5/5 | 5/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-19 | A+ | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-18 | A+ | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-15 | A+ | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-14 | A+ | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-13 | A+ | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-12 | A+ | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yue Tsang | Founder, Chairperson & Chief Executive Officer | 17M | — |
| Soo Ghee Lee | Chief Administrative Officer | 2M | — |
| See Man Yeung | Financial Controller & Executive Director | 876.0K | female |
| Kai Wing Yip | Chief Technology Officer & Executive Director | 772.0K | male |
| Chi Ming Cheng | Chief Financial Officer & Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0919.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
